Estrogen Replacement Therapy After Breast Cancer: A 12-Year Follow-Up

@inproceedings{Peters2001EstrogenRT,
  title={Estrogen Replacement Therapy After Breast Cancer: A 12-Year Follow-Up},
  author={George Nathaniel Henry Peters and Tomasina Fodera and Jennifer L. Sabol and Stephen R. Jones and David M Euhus},
  year={2001}
}
Background: In the United States, estrogen replacement therapy ERT is discouraged in breast cancer survivors because of concerns that hormones may reactivate the disease. Because ERT can improve quality of life and decrease morbidity from osteoporosis and cardiovascular disease, however, this policy is increasingly being challenged. 

Similar Papers

Topics from this paper.

Citations

Publications citing this paper.